Navigation Links
Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Date:9/29/2009

p>

This News Release may contain forward-looking information that involves risks and uncertainties, including statements about the use of the ThinPrep Pap test, ThinPrep imaging system and the ThinPrep integrated imager. There can be no assurance the system will achieve the benefits described herein and that such benefits will be replicated in any particular manner by a particular laboratory as the actual effect of the use of the ThinPrep Pap test, ThinPrep imaging system and the ThinPrep integrated imager can only be determined on a case-by-case basis depending on the particular laboratory, screening personnel and patient sample in question. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based. Certain factors that could adversely affect the Company's business and prospects are described in Hologic filings with the Securities and Exchange Commission.

Hologic and ThinPrep are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

    Contact:  For Investors:                            For Media:
              Deborah R. Gordon                         Jeff Keene
              Vice President, Investor Relations        Product Marketing
              Hologic, Inc.                             Hologic, Inc.
              (781) 999-7716                            (508) 263-8957

SOURCE Hologic, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
2. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
5. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
6. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
7. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
8. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
9. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
10. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
11. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... WILMINGTON, Del. and MUNICH , ... venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation ... today its first interim results of the J enaValve ... Safety I n Pa T ients with S E ... Paris . JUPITER is a post-market registry ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
(Date:5/22/2013)... 22, 2013  Healthcare providers are turning ... management (ECM) solution, for a deeper ... .  These organizations identified enterprise content management ... use OnBase to optimize their Meditech system ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
Breaking Medicine Technology:First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Is There Finally A Way To Stop Severe Excessive Sweating? 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3
... the constructability-focused structural engineering firm, has completed its design-build ... Willard, OH.  Ruby acted as the engineer of record ... third in a series of construction projects for Mercy. ... Heart Pavilion in Toledo and Mercy Hospital of Tiffin, ...
... Pharmaceuticals, Inc. (AMEX: AEN ), a developer ... announced today that it will hold its 2nd quarter ... at 2:00pm EDT. James S. Kuo, M.D., M.B.A., Adeona,s ... Company,s drug development programs and commercialization efforts of ...
Cached Medicine Technology:Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project 2Adeona to Host Second Quarter 2011 Investor Conference Call 2Adeona to Host Second Quarter 2011 Investor Conference Call 3Adeona to Host Second Quarter 2011 Investor Conference Call 4
(Date:5/23/2013)... On May 23, Voices Against Brain Cancer, an organization ... School senior Max Merget for turning his graduation party into ... Patch.com article, Max Merget has battled brain cancer four ... malignant tumor in the dominant, left side of brain, at ... came back a year later when he was four and ...
(Date:5/23/2013)... May 23, 2013 After working continuously ... beta testing regimes, Shopping Cart Elite officially ... Redsandmotorsports.com is an Arizona based online store retailing in ... , “Addition of new stores to our clientele has ... Cart Elite, Igor Soshkin. “We are extremely elated with ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Spring is ... Assisi Veterinary Hospital urges pet owners to be aware of ... treatments for pet allergies. , An allergy is a state ... called an allergen. Allergen exposure may cause an over-reaction. This ... against infection and disease, can actually be harmful to the ...
(Date:5/23/2013)... 23, 2013 Ezell Law Firm is ... For 25 years, Jeff Ezell has served the ... a focus on personal injury cases . , ... insurance companies, he offers clients a uniquely qualified level ... which enables him better serve his clients. , ...
(Date:5/23/2013)... 2013 Greenville Oral & Maxillofacial ... members and doctors have recently completed their bi-annual ... an Automated External Defibrillator (AED). ... medical device designed to analyze the heart rhythm ... ventricular fibrillation to restore the heart rhythm to ...
Breaking Medicine News(10 mins):Health News:Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle 2Health News:Shopping Cart Software Provider, Shopping Cart Elite Officially Announces the Launch Of Redsandmotorsports.com 2Health News:Allergy Season Affects Pets as Well as People 2Health News:Ezell Law Firm Celebrates 25 Years in Practice 2Health News:Greenville Oral & Maxillofacial Surgeons Announce CPR Re-Certification 2
... Investor Conferences in ... ... OREX ), a biopharmaceutical company focused on the treatment,of obesity ... events for November 2008, which includes,the teleconference and webcast of its ...
... Healthcare,Corporation (Nasdaq: UAHC ), which owns and ... organization in,Tennessee, today announced financial results for its ... increased five percent to $6.5 million for the ... revenues of $6.2 million for,the first quarter of ...
... 4 As biopharmaceutical,companies focus on line ... (FDC) products have become an,increasingly important segment ... better,understand the development strategies and issues for ... by Best Practices, LLC, with insights available,in ...
... HOUSTON, Nov. 4 Carriage Services, Inc.,(NYSE: CSV ) today announced results for the third quarter ended ... as follows:, Third Quarter Selected Financial Results (amounts in millions, except per share amounts), ... Q3 ... ...
... study says , , TUESDAY, Nov. 4 (HealthDay News) -- Girls ... of their movements than boys with the common mental disorder, ... Nov. 4 issue of Neurology , found that girls ... disorder did twice as well as boys with ADHD in ...
... says , , TUESDAY, Nov. 4 (HealthDay News) -- Teens ... less likely to continue using these drugs if they ... rather than short-term drug therapy, a new study found. ... be effective in treating opioid addiction, but only limited ...
Cached Medicine News:Health News:Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008 2Health News:United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2009 First Quarter Results 6Health News:New Study Provides Benchmarks for Fixed-Dose Combination (FDC) Drug Development 2Health News:Carriage Services Announces Third Quarter 2008 Results 2Health News:Carriage Services Announces Third Quarter 2008 Results 3Health News:Carriage Services Announces Third Quarter 2008 Results 4Health News:Carriage Services Announces Third Quarter 2008 Results 5Health News:Carriage Services Announces Third Quarter 2008 Results 6Health News:Carriage Services Announces Third Quarter 2008 Results 7Health News:Carriage Services Announces Third Quarter 2008 Results 8Health News:Carriage Services Announces Third Quarter 2008 Results 9Health News:Carriage Services Announces Third Quarter 2008 Results 10Health News:Carriage Services Announces Third Quarter 2008 Results 11Health News:Carriage Services Announces Third Quarter 2008 Results 12Health News:Extended Therapy Helps Drug-Addicted Teens 2Health News:Extended Therapy Helps Drug-Addicted Teens 3
... Orion incorporates superior optics in a durable ... fully adjustable headband, made of white molded ... the brow, directing the spot along your ... the headband position the cable diagonally over ...
... of intelligent Pulse Oximeter technology. New ... over 7 years by a dedicated ... non-invasive oxygen saturation monitoring. The combination ... sophisticated saturation sensor designs using our ...
... the Novametrix' family of capnography products. Along ... are the only handheld, mainstream capnographs available ... patient's airway condition and ventilatory status. Based ... capnographs, we miniaturized the size, not the ...
A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....
Medicine Products: